insights_auto
Why is GANX down 3.70%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
US$1.04
arrow_downward
-3.70%(-0.040) 1D
ኖቬም 13, 12:28:20 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
US$1.12
High
US$1.14
Low
US$1.01
Mkt. cap
46.31 ሚ
Avg. vol.
529.90 ሺ
Volume
132.39 ሺ
52-wk high
US$4.34
52-wk low
US$0.94
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
Open
US$1.12
High
US$1.14
Low
US$1.01
Mkt. cap
46.31 ሚ
Avg. vol.
529.90 ሺ
Volume
132.39 ሺ
52-wk high
US$4.34
52-wk low
US$0.94
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
News stories
From web sources and news partners
24/7 Wall St.
·
ከ26 ደቂቃዎች በፊት
The S&P 500 Has a "Pure Value" Version. RPV Gives Its Cheapest Stocks the Biggest Weights
TradingNEWS
·
ከ27 ደቂቃዎች በፊት
Stock Market Today: S&P 500 7,510 (-1.1%), Nasdaq -1.9%, Dow DJI -0.3%; 7,845 Target as AMD -9.7%
24/7 Wall St.
·
ከ25 ደቂቃዎች በፊት
S&P 500 Slides Nearly 1% at Midday as Tech Absorbs Most of the Hit
TradingView
·
ከ3 ሰዓቶች በፊት
Wall Street Divided on S&P 500: Which ETFs Could Benefit in 2027?
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com